- Every Spring is Prom time for many teenagers. The MSK 2015 Pediatric Spring Annual Prom was held Thursday, May 28, with donated dresses and tuxedos, prizes, and make-up. ABC WHAS11 News reported on this year’s event.
- A May 29 online article in Genetic Engineering & Biotechnology News, discusses a research collaboration between MSKCC and Peregrine Pharmaceuticals that will investigate cancer treatments that combine phosphatidylserine (PS)-targeting agents with other “checkpoint inhibitors or immune stimulating agents”. Continue reading
Category Archives: In the News
New Innovations in Cancer Research
Here are a few highlights of cancer research news that have recently caught my attention:
- In a head-to-head clinical trial comparing standard chemotherapy with the immunotherapy drug nivolumab, researchers at Johns Hopkins found that on average patients treated with nivolumab lived 3.2 months longer than those receiving chemotherapy. Results of the trial have been published in NEJM.
- The European Society for Medical Oncology (ESMO) recently announced the publication of the ESMO Magnitude of Clinical Benefits Scale, a tool to assist oncologists in assessing effective cancer medicines for their patients. Read more about this tool in Annals of Oncology. Continue reading
A Nutrition Science Coverage Hoax, ASCO Highlight Videos, and more Blog Buzz
Some recent news from around the internet…
- For those unable to make it out to Chicago, the ASCO meeting videos are available online. Check out the free series of brief Highlights of the Day organized by specialty.
- Kevin Smith of Duke discusses attempts by publishers to control where authors may post and link to their own work during embargo periods. He then goes on to explain why this concept translates poorly into the real academic publishing world. According to Smith;
It appears that Elsevier is making a distinction between an author’s personal website or blog and the repository at the institution where that author works. Authors are, I think, able to post final manuscripts to the former for public access, but posting to the latter must be restricted only to internal users for the duration of the newly-imposed embargo periods. – See more